Results
18
Companies which are more than 50% undervalued based on analyst price target.
18 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
IMP A SDB New | SEK 35.05 | -3.8% | 46.7% | SEK 9.9b | SEK 53.87 | PS430.4x | E42.5% | n/a | ||
CRAD B | SEK 29.30 | -1.5% | -30.6% | SEK 983.8m | SEK 49.00 | PE17x | E27.4% | n/a | ||
SEZI | SEK 5.78 | -0.3% | -22.2% | SEK 765.7m | SEK 12.25 | PS13.8x | E75.2% | n/a | ||
MNTC | SEK 24.30 | -2.8% | -49.1% | SEK 621.3m | SEK 42.67 | PS2.3x | E116.7% | 0% | ||
INTEG B | SEK 18.65 | -2.1% | -59.1% | SEK 361.8m | SEK 40.25 | PS3.5x | E69.2% | n/a | ||
ORT B | SEK 9.18 | -1.1% | -12.6% | SEK 340.4m | SEK 20.00 | PS5.3x | E96.6% | n/a | ||
ACARIX | SEK 0.28 | -2.5% | 44.9% | SEK 292.5m | SEK 0.45 | PS51.5x | E110.4% | n/a | ||
NEOLA | SEK 2.00 | -2.0% | 2.6% | SEK 140.3m | SEK 3.10 | PS12.7x | S39.8% | n/a | ||
PTRK | SEK 8.60 | 0.9% | -46.9% | SEK 139.8m | SEK 23.11 | PE4.3x | S10.5% | n/a | ||
ARCOMA New | SEK 10.55 | -1.9% | 32.7% | SEK 139.1m | SEK 16.00 | PE10.7x | E7.9% | n/a | ||
SCIB | SEK 0.42 | -0.5% | -50.1% | SEK 91.3m | SEK 1.60 | PS3.4x | E87.7% | n/a | ||
KONT | SEK 2.64 | -4.3% | -1.9% | SEK 84.6m | SEK 5.40 | PE85.3x | E99.6% | n/a | ||
QLINEA | SEK 0.68 | -11.4% | -81.6% | SEK 79.6m | SEK 7.00 | PS22.8x | E47.9% | n/a | ||
CLS B | SEK 3.80 | 3.3% | -86.2% | SEK 76.6m | SEK 14.00 | PS4.1x | E63.8% | n/a | ||
EPIS B | SEK 0.12 | -3.6% | -88.1% | SEK 76.5m | SEK 0.35 | PS6.1x | E8.4% | n/a | ||
DIGN | SEK 0.93 | 6.3% | -57.6% | SEK 74.5m | SEK 5.50 | PS0.9x | E118.7% | n/a | ||
ICO | SEK 4.33 | 1.6% | -62.5% | SEK 68.9m | SEK 16.75 | PS2.8x | E-17.6% | n/a | ||
CMOTEC B | SEK 1.47 | 2.8% | -45.6% | SEK 34.3m | SEK 3.10 | PS6.8x | E29.0% | n/a |